If the drug is back to the market and I have every reason to believe that it will, all the shares will be passed on to children and grand children. This is huge product. Amgen has almost 100% monopoly on the Epogen red blood cells producign drug for 20 years and is making some 56B a year!
very compelling reason to believe in Affy. I had no idea Amgen was making that much. I know this the USA is a nation of deadbeats with diabetes and now with Obamacare - there should be millions more diabetics with kidney problems seeking treatment .... expanding market for Omontys.